期刊文献+

活性氧在青蒿素及其衍生物抗肿瘤作用机制中的研究进展 被引量:6

活性氧在青蒿素及其衍生物抗肿瘤作用机制中的研究进展
下载PDF
导出
摘要 青蒿素及其衍生物目前已成为抗疟的一线药物,近年来,很多研究已经证实青蒿素及其衍生物具有明显的抗肿瘤作用。其细胞毒性效应主要与活性氧(ROS)的产生有关。其可能作用靶点包括血红素、线粒体及某些特定的蛋白等。其抗肿瘤作用包括抑制肿瘤细胞增殖、抑制肿瘤新生血管生成、抗肿瘤细胞侵袭和转移,以及促进肿瘤细胞凋亡等。青蒿素类药物广谱、高效、低毒,能选择性杀伤肿瘤细胞,逆转肿瘤的多重耐药现象,与多种化疗药物具有协同、增效作用,有望被开发成为新型抗肿瘤药。 The artemisinin and its derivatives are the frontline drugs for the treatment of malaria at present, which has been proved to have significant anti-tumor effects in recent years. Its cytotoxic effect is primarily concerned with the generation of active oxygen species (ROS). The possible targets including heine, mitochondrial and certain proteins. Its anti-tumor effects including inhibition of proliferation, angiogenesis, invasion and metastasis of tumor cells, induction of apoptosis. In summary, the artemisinin compounds,which with broad-spectrum, high efficiency, and low toxicity, can selectively kill cancer cells, retroconverse themultidrug resistance for cancer cells,and also have chemosensitizing/synergistic effects with many chemotherapy drags.Therefor, they are expected to be developed as new anticancer drugs.
出处 《当代医学》 2013年第16期13-15,共3页 Contemporary Medicine
关键词 青蒿素 活性氧 血红素 抗肿瘤作用 Artemisinin Active oxygen species Heme Antitumor action.
  • 相关文献

参考文献1

二级参考文献33

  • 1Adjuik, M., Babiker, A., Garner, P., Olliaro, P., Taylor, W., White, N., 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet, 363(9402):9-17. [doi: 10.1016/S0140-6736(03)15162-8].
  • 2Altieri, D.C., 2003. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22(53): 8581-8589. [doi:10.1038/sj.onc.1207113].
  • 3Berger, T.G., Dieckmann, D., Efferth, T., Schultz, E.S., Funk, J.O., Baur, A., Schuler, G., 2005. Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Reports, 14(6): 1599-1603.
  • 4Bossy-Wetzel, E., Green, D.R., 1999. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem., 274(25):17484-17490. [doi: 10.1074/jbc.274.25.17484].
  • 5Brama, M., Rhodes, N., Hunt, J., Ricci, A., Teghil, R., Migliaccio, S., Rocca, C.D., Leccisotti, S., Lioi, A., Scandurra, M., et al., 2007. Effect of titanium carbide coating on the osseointegration response in vitro and in vivo. Biomaterials, 28(4):595-608. [doi:10.1016/j.biomaterials.2006.08.018].
  • 6Chou, A.J., Gorlick, R., 2006. Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev. Anticancer Ther., 6(7):1075-1785. [doi:10. 1586/14737140.6.7.1075].
  • 7Dell'Eva, R., Pfeffer, U., Vene, R., Anfosso, L., Forlani, A., Albini, A., Efferth, T., 2004. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem. Pharmaeol., 68(12):2359-2366. [doi:10.1016/j.bcp.2004.08.021].
  • 8Doherty, J.F., Sadiq, A.D., Bayo, L., Alloueche, A., Olliaro, P., Milligan, P., von Seidlein, L., Pinder, M., 1999. A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine- pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Trans. R. Soc. Trop. Med. Hyg., 93(5):543-546. [doi: 10.1016/S0035-9203(99)90376-0].
  • 9Du, J.H., Zhang, H.D., Ma, Z.J., Ji, K.M., 2010. Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother. Pharmacol., 65(5):895-902. [doi:lO. 1007/s00280-009-1095-5].
  • 10Efferth, T., Kaina, B., 2010. Toxicity of the antimalarial artemisinin and its dervatives. Crit. Rev. Toxicol., 40(5): 405-421. [doi:10.3109/10408441003610571].

共引文献14

同被引文献73

引证文献6

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部